Quarterly report pursuant to Section 13 or 15(d)

Revenue and Accounts Receivable (Tables)

v3.5.0.2
Revenue and Accounts Receivable (Tables)
6 Months Ended
Jun. 30, 2016
Receivables [Abstract]  
Schedule of Revenue by Service Type
Revenue by service type for the three and six months ended June 30, 2016 and 2015 is comprised of the following (in thousands): 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Biopharma Services
$
4,219

 
$
2,675

 
7,569

 
$
6,006

Clinical Services
2,542

 
1,251

 
4,998

 
2,124

Discovery Services
240

 
259

 
502

 
425

 
$
7,001

 
$
4,185

 
$
13,069

 
$
8,555

Schedule of Accounts Receivable by Service Type
Accounts receivable by service type at June 30, 2016 and December 31, 2015 consists of the following (in thousands): 

June 30,
2016
 
December 31,
2015
Biopharma Services
$
5,144

 
$
3,238

Clinical Services
7,119

 
3,733

Discovery Services
345

 
314

Allowance for doubtful accounts
(664
)
 
(664
)

$
11,944

 
$
6,621



At June 30, 2016, accounts receivable includes approximately $1,425,000 of unbilled revenue for clinical services provided by our location in California.

Allowance for Doubtful Accounts (in thousands)
Balance, December 31, 2015
$
664

Additions to allowance for doubtful accounts

Balance, June 30, 2016
$
664

Schedule of Clinical Services Revenue (As a Percent of Total Revenue)
The breakdown of our Clinical Services revenue (as a percent of total revenue) is as follows:

 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2016
 
2015
 
2016
 
2015
Medicare
12%
 
7%
 
13%
 
7%
Other insurers
17%
 
6%
 
19%
 
6%
Other healthcare facilities
7%
 
9%
 
6%
 
8%
 
36%
 
22%
 
38%
 
21%